|
|
|
|
| LEADER |
02013nmm a2200445 u 4500 |
| 001 |
EB001927355 |
| 003 |
EBX01000000000000001090257 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
210123 ||| eng |
| 020 |
|
|
|a 9780132172806
|
| 020 |
|
|
|a 0132168146
|
| 020 |
|
|
|a 0132172801
|
| 050 |
|
4 |
|a QH447
|
| 100 |
1 |
|
|a Smith, Moyra
|
| 245 |
0 |
0 |
|a Investigating the human genome
|b insights into human variation and disease susceptibility
|c Moyra Smith
|
| 260 |
|
|
|a Upper Saddle River, N.J.
|b Pearson Education
|c 2011
|
| 300 |
|
|
|a viii, 216 pages
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references (pages 171-202) and index
|
| 505 |
0 |
|
|a Genome architecture and sequence variation in health and disease -- Genes and transcripts : insight into regulation at different levels -- Modifications : epigenetics and epigenomics -- Gene environment interactions : damage and control -- Phenotypes, phenocopies, pathways, and interactions -- Dynamic function, synaptic activity, and plasticity -- Late onset neurodegenerative diseases -- Genes and genomes in cancer : targeted therapies -- Functional genomics and personalized medicine
|
| 653 |
|
|
|a Génome humain
|
| 653 |
|
|
|a Disease susceptibility / http://id.loc.gov/authorities/subjects/sh85037625
|
| 653 |
|
|
|a Human genome / fast
|
| 653 |
|
|
|a Human genome / http://id.loc.gov/authorities/subjects/sh94002900
|
| 653 |
|
|
|a Biology / hilcc
|
| 653 |
|
|
|a Prédisposition morbide
|
| 653 |
|
|
|a Disease Susceptibility
|
| 653 |
|
|
|a Genetic Predisposition to Disease
|
| 653 |
|
|
|a Genetics / hilcc
|
| 653 |
|
|
|a Health & Biological Sciences / hilcc
|
| 653 |
|
|
|a Disease susceptibility / fast
|
| 653 |
|
|
|a Genome, Human
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b OREILLY
|a O'Reilly
|
| 776 |
|
|
|z 9780132172806
|
| 776 |
|
|
|z 0132172801
|
| 776 |
|
|
|z 9780132168144
|
| 856 |
4 |
0 |
|u https://learning.oreilly.com/library/view/~/9780132172806/?ar
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 611/.01816
|
| 082 |
0 |
|
|a 500
|